Literature DB >> 4625817

Metabolism of disodium ethane-1-hydroxy-1,1-diphosphonate (disodium etidronate) in the rat, rabbit, dog and monkey.

W R Michael, W R King, J M Wakim.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4625817     DOI: 10.1016/0041-008x(72)90007-5

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


× No keyword cloud information.
  12 in total

1.  The effects of various diphosphonates on a rat model of cardiac calciphylaxis.

Authors:  I Y Rosenblum; H E Black; J F Ferrell
Journal:  Calcif Tissue Res       Date:  1977-06-28

Review 2.  Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease.

Authors:  H Fleisch
Journal:  Drugs       Date:  1991-12       Impact factor: 9.546

3.  Different schedules of administration of (3 amino-1-hydroxypropylidene)-1, 1 bisphosphonate induce different changes in pig bone remodeling.

Authors:  M C de Vernejoul; A Pointillart; C Bergot; J Bielakoff; C Morieux; A M Laval Jeantet; L Miravet
Journal:  Calcif Tissue Int       Date:  1987-03       Impact factor: 4.333

4.  A micropuncture study of growth cartilage in phosphonate (EHDP) induced rickets.

Authors:  D S Howell; O E Muniz; L N Blanco; J C Pita
Journal:  Calcif Tissue Int       Date:  1980       Impact factor: 4.333

5.  The tissue distribution of clodronate (dichloromethylene bisphosphonate) in mice. The effects of vehicle and the route of administration.

Authors:  J Mönkkönen; P Ylitalo
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Jul-Sep       Impact factor: 2.441

Review 6.  Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use.

Authors:  S Patel; A R Lyons; D J Hosking
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

7.  Low dose intravenous 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD) for the treatment of Paget's disease of bone.

Authors:  J A Cantrill; H M Buckler; D C Anderson
Journal:  Ann Rheum Dis       Date:  1986-12       Impact factor: 19.103

8.  Paget's disease of bone. An update on management.

Authors:  D J Hosking
Journal:  Drugs       Date:  1985-08       Impact factor: 9.546

9.  The pharmacokinetics and distribution of pamidronate for a range of doses in the mouse.

Authors:  C R Hoggarth; R Bennett; P T Daley-Yates
Journal:  Calcif Tissue Int       Date:  1991-12       Impact factor: 4.333

10.  Sodium EDTA enhances intestinal absorption of two bisphosphonates.

Authors:  M Janner; R C Mühlbauer; H Fleisch
Journal:  Calcif Tissue Int       Date:  1991-10       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.